Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey
Articles > Article · 2021
Authors: Serdar Celik, Fuat KIZILAY, KUTSAL YÖRÜKOĞLU, Haluk Ozen, BÜLENT AKDOĞAN, VOLKAN İZOL, YILDIRIM BAYAZIT, GÜVEN ASLAN, Sinan Sozen, Sümer BALTACI, TALHA MÜEZZİNOĞLU, Fehmi Narter, LEVENT TURKERI
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, Journal Indexed in SCI Expanded, International, 2021, vol 20, pp 19-25
DOI: 10.4274/uob.galenos.2020.1677
Summary
Objective: The aim of this study is to investigate the relevance of the Epstein criteria for the 12-core transrectal prostate biopsy (TRUS-Bx) scheme with the evaluation of clinicopathologic data recorded in the Urologic Cancer Database - Prostate (UroCaD-P), Urooncology Association, Turkey (UOAT).